Nephros (NASDAQ:NEPH) is a company engaged in the development and commercialization of high-performance water purification products and pathogen detection systems for medical and commercial markets. They are focused on addressing the critical need for pure water in healthcare environments, and their product portfolio includes dialysis water purification, and infection control solutions. Nephros aims to improve patient outcomes and provide value through innovative filtration technologies. Their projects include advancing hemodiafiltration technology for kidney dialysis patients and expanding into water safety solutions to combat waterborne pathogens in various settings. With a clear vision towards enhancing water purity and safety, Nephros is committed to delivering cutting-edge solutions to meet the evolving needs of their customers.